federal_register: 00-33216
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00-33216 | Cooperative Arrangement Between the United States Food and Drug Administration and Therapeutic Goods Administration, Republic of Australia Regarding the Exchange of Information on Current Good Manufacturing Practice Inspections of Human Pharmaceutical Facilities | Notice | The Food and Drug Administration (FDA) is providing notice of cooperative arrangement between the Food and Drug Administration, Department of Health and Human Services, United States of America and the Therapeutic Goods Administration, Department of Health and Aged Care, Commonwealth of Australia. The purpose of the arrangement is to enable each administration to obtain information that will enable it to make its own independent facility and/or product regulatory decisions in the assessment of current good manufacturing practices compliance, public health protection, and approval of new drugs. It also will facilitate more efficient use of resources for each organization in meeting their statutory requirements without reduction of public safety or regulatory responsibilities. | 2000-12-29 | 2000 | 12 | https://www.federalregister.gov/documents/2000/12/29/00-33216/cooperative-arrangement-between-the-united-states-food-and-drug-administration-and-therapeutic-goods | https://www.govinfo.gov/content/pkg/FR-2000-12-29/pdf/00-33216.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is providing notice of cooperative arrangement between the Food and Drug Administration, Department of Health and Human Services, United States of America and the Therapeutic Goods Administration, Department of... |